Literature DB >> 2121537

Differential expression of the neural cell adhesion molecule NCAM 140 in human pituitary tumors.

M C Aletsee-Ufrecht1, K Langley, O Gratzl, M Gratzl.   

Abstract

We have analyzed the expression of the intracellular marker protein neuron specific enolase (NSE), synaptophysin (SYN) and of the cell surface marker NCAM (neural cell adhesion molecule) in both normal hypophysis and in pituitary adenomas in order to explore their potential use as diagnostic tools. All adenomas (4 prolactinomas, 3 growth hormone (GH) producing adenomas and 4 inactive adenomas) showed SYN and NSE immunoreactivity on tissue sections and this was confirmed by immunoblots. NCAM 140 (an isoform of NCAM with molecular mass 140 kDa) was detected by immunoblotting in normal human adenohypophysis, in all GH adenomas, and in three out of four inactive adenomas, but not in prolactinomas. Using highly sensitive techniques, NCAM immunoreactivity was observed by electron microscopy in all adenomas. These data indicate that NCAM 140 is a constituent of the cell surface of endocrine cells in both normal human adenohypophysis and its tumors. Since prolactinomas express very low levels of NCAM 140 compared to other hypophyseal tumors its virtual absence could be used for differential diagnosis. A combined analysis of NCAM, SYN and NSE could be useful to characterize inactive adenomas which are not immunoreactive for pituitary hormones and which may contain no or only low levels of the alpha chain of the glycoprotein hormones.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121537     DOI: 10.1016/0014-5793(90)80445-o

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Paucity of retinoic acid receptor alpha (RAR alpha) nuclear immunostaining in gliomas and inability of retinoic acid to influence neural cell adhesion molecule (NCAM) expression.

Authors:  B K Kleinschmidt-DeMasters; E A Orr; E Savelieva; G C Owens; C A Kruse
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 2.  Mechanisms of storage and exocytosis in neuroendocrine tumors.

Authors:  Manfred Gratzl; Martin Breckner; Christian Prinz
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

3.  Expression of neural cell adhesion molecule in normal and neoplastic human neuroendocrine tissues.

Authors:  L Jin; J J Hemperly; R V Lloyd
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

Review 4.  Ubiquitous Neural Cell Adhesion Molecule (NCAM): Potential Mechanism and Valorisation in Cancer Pathophysiology, Drug Targeting and Molecular Transductions.

Authors:  S Sowparani; P Mahalakshmi; J Pushpa Sweety; Arul Prakash Francis; U M Dhanalekshmi; N Selvasudha
Journal:  Mol Neurobiol       Date:  2022-07-12       Impact factor: 5.682

5.  Elevated cell invasion is induced by hypoxia in a human pituitary adenoma cell line.

Authors:  Daizo Yoshida; Akira Teramoto
Journal:  Cell Adh Migr       Date:  2007-01-27       Impact factor: 3.405

6.  Neural cell adhesion molecule expression in human pituitary adenomas.

Authors:  B K Kleinschmidt-DeMasters; D R Conway; W A Franklin; K O Lillehei; C A Kruse
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Expression of the Neural Cell Adhesion Molecule NCAM by Peptide- and Steroid-Producing Endocrine Cells and Tumors: Alternatively Spliced Forms and Polysialylation.

Authors:  Georgia Lahr; Artur Mayerhofer
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

Review 8.  Gene expression in prolactinomas: a systematic review.

Authors:  Justin Seltzer; Thomas C Scotton; Keiko Kang; Gabriel Zada; John D Carmichael
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

9.  Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.

Authors:  G A Mendes; T Haag; G Trott; C G S L Rech; N P Ferreira; M C Oliveira; M B Kohek; J F S Pereira-Lima
Journal:  Braz J Med Biol Res       Date:  2017-12-11       Impact factor: 2.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.